ATLANTA – Crawford & Company (NYSE: CRD-A and CRD-B), a global leader in claims management and outsourcing solutions, announced the appointment of Joel Murphy as an independent director to its board of directors, effective Monday. Murphy’s 35 years of experience in capital markets and real estate development is expected to contribute significantly to the company’s strategic direction and growth.
Murphy’s previous roles include serving as President, CEO and Chairman of the Board of Directors Preferred apartment communities (NYSE: NYSE:), as well as founding and leading New Market Properties, LLC. He currently serves as CEO of Murphy Capital and Advisory Group LLC, where he focuses on growth and capital strategies for various companies.
Rohit Verma, CEO of Crawford & Company, expressed confidence in Murphy’s ability to enhance the Board’s expertise, citing his trusted investment perspective and strategic acumen. Jesse C. Crawford Jr., Non-Executive Chairman of the Board of Directors, also welcomed Murphy’s new visions, which are expected to benefit the company and its shareholders.
Murphy’s educational accomplishments include being a Phi Beta Kappa graduate in Economics from the University of North Carolina at Chapel Hill and a summa cum laude graduate in Law Review from the University of Georgia Law School. His past accolades include being named one of Atlanta’s Most Admired CEOs by the Atlanta Business Chronicle. Furthermore, he is a current member of the Board of Directors of Orvis Corporation.
Headquartered in Atlanta, Crawford & Company operates in more than 70 countries, providing a broad range of services to insurers and self-insured entities. The Company has two classes of stock, Class B Common Stock (CRD-B) which has voting rights and Class A Common Stock (CRD-A) which has protection without voting rights.
This expansion of Crawford’s Board of Directors to ten directors is part of the company’s ongoing efforts to harness diverse expertise and leadership to guide future growth. Information regarding the hiring of Joel Murphy is based on a press release from Crawford & Company.
In other recent news, Agilent Technologies (NYSE:) reported mixed results for the second quarter of 2024. Despite a 7.4% decline in revenue, totaling $1.573 billion, the company’s earnings per share of $1.22 beat expectations.
The full-year core revenue outlook has been revised, forecasting a decline of between 4.3% and 5.4%, with earnings per share expected to range between $5.15 and $5.25. In response, Agilent announced plans to simplify its cost structure, aiming to achieve annual savings of $100 million by the end of the fiscal year, and intends to repurchase $750 million of its common stock in the latter half of the year.
In other recent developments, Citi reiterated its neutral stance on Agilent, following an announcement from Alnylam Pharmaceuticals regarding successful key results from its HELIOS-B clinical study.
The trial evaluated vutrisiran, brand name Amvuttra, for the treatment of ATTR amyloidosis with cardiomyopathy, meeting its primary endpoints. Citi expects that positive trial results will likely lead to an expanded designation for Amvuttra to include ATTR-CM. Agilent’s NASD business unit, which supplies Alnylam, is expected to generate revenue of approximately $300 million for fiscal 2024.
Agilent also launched two new mass spectrometry products, the Agilent 7010D Triple Quadrupole GC/MS System and the Agilent ExD Cell, with the goal of enhancing accuracy and sensitivity in scientific measurements.
These launches are part of Agilent’s commitment to customer-driven innovation, addressing the needs of diverse sectors including bio/pharmaceutical, life sciences research, food, and environment.
InvestingPro Insights
As Crawford & Company welcomes Joel Murphy to its Board of Directors, investors may look at different metrics and insights to understand the company’s financial health and position in the market. Here are some key insights from InvestingPro that may be of interest:
InvestingPro data highlights that Crawford & Company’s market capitalization is $38.81 billion, indicating its significant presence in the industry. The company is trading at a price-to-earnings (P/E) ratio of 31.28, indicating a higher valuation compared to some of its peers, reflecting the market’s optimistic outlook for future earnings growth. The company’s gross profit margin is a solid 50.63% over the trailing twelve months as of Q2 2024, indicating efficient operations and cost management.
A noteworthy InvestingPro tip is that the company’s management has been aggressively buying back shares, a move that can often be interpreted as a signal of confidence in the company’s future prospects and a potential increase in shareholder value.
Furthermore, Crawford & Company has maintained dividends for 13 consecutive years, demonstrating its commitment to providing consistent returns to shareholders. This track record is consistent with Murphy’s extensive background in capital markets and may enhance investor confidence in the company’s financial stability and long-term strategy.
For readers interested in diving deeper into a company’s financials and getting more exclusive insights, InvestingPro offers additional tips. Visit https://www.investing.com/pro/CRD-A for comprehensive analysis. Remember to use the coupon code Pronews24 Get an extra 10% off Pro and Pro+ subscriptions annually or every two years. There are 13 additional tips available from InvestingPro, providing a broader perspective on a company’s performance and outlook.
This article was created with the power of artificial intelligence and reviewed by an editor. For more information, see our terms and conditions.
